Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M529Revenue $M402Net Margin (%)-0.6Altman Z-Score1.5
Enterprise Value $M869EPS $-0.1Operating Margin %3.4Piotroski F-Score5
P/E(ttm)--Beneish M-Score-2.3Pre-tax Margin (%)-0.9Higher ROA y-yY
Price/Book1.810-y EBITDA Growth Rate %--Quick Ratio1.9Cash flow > EarningsY
Price/Sales1.25-y EBITDA Growth Rate %--Current Ratio2.8Lower Leverage y-yN
Price/Free Cash Flow28.6y-y EBITDA Growth Rate %74.6ROA % (ttm)-0.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-0.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M35.8ROIC % (ttm)-8.3Gross Margin Increase y-yY

Gurus Latest Trades with AMRI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMRIKen Fisher 2015-12-31 Add$17.08 - $20.5
($19.03)
$ 14.76-22%Add 19.06%203,450
AMRIKen Fisher 2015-09-30 Buy 0.01%$17.23 - $22.2
($20.37)
$ 14.76-28%New holding170,876
AMRIJoel Greenblatt 2014-09-30 Sold Out -0.03%$18.7 - $22.89
($20.45)
$ 14.76-28%Sold Out0
AMRIJoel Greenblatt 2014-06-30 Reduce-0.03%$14.63 - $19.89
($16.89)
$ 14.76-13%Reduce -47.95%102,934
AMRIGeorge Soros 2014-06-30 Sold Out -0.01%$14.63 - $19.89
($16.89)
$ 14.76-13%Sold Out0
AMRIGeorge Soros 2014-03-31 Buy 0.01%$10.08 - $19.91
($13.57)
$ 14.769%New holding48,700
AMRIJoel Greenblatt 2013-09-30 Buy 0.1%$10.81 - $13.72
($12.29)
$ 14.7620%New holding228,216
AMRIJohn Rogers 2013-03-31 Sold Out -0.04%$5.28 - $10.84
($7.56)
$ 14.7695%Sold Out0
AMRIJohn Rogers 2012-12-31 Reduce-0.01%$3.45 - $5.5
($4.25)
$ 14.76247%Reduce -27.34%372,844
AMRIJohn Rogers 2012-06-30 Buy 0.03%$2.32 - $3.22
($2.81)
$ 14.76425%New holding473,769
AMRIFirst Eagle Investment 2010-12-31 Sold Out $5.05 - $6.93
($5.91)
$ 14.76150%Sold Out0
AMRIFirst Eagle Investment 2010-06-30 Buy $5.1 - $8.86
($7.07)
$ 14.76109%New holding10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMRI is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AMRI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
D AMBRA THOMAS EChairman, Board of Directors 2015-11-09Sell50,000$19.6-24.69view
D AMBRA CONSTANCE M10% Owner 2015-11-09Sell50,000$19.6-24.69view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-08-17Sell1,000$20.45-27.82view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-08-07Sell5,000$21.06-29.91view
D AMBRA THOMAS E PHDDirector 2015-06-10Sell20,000$19.77-25.34view
D AMBRA CONSTANCE M10% Owner 2015-06-10Sell20,000$19.77-25.34view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-06-08Sell5,000$19.99-26.16view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-06-04Sell787$19.58-24.62view
Marth William SPresident and CEO 2015-06-04Buy10,000$19.98-26.13view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-06-02Sell3,750$19.39-23.88view

Press Releases about AMRI :

Quarterly/Annual Reports about AMRI:

News about AMRI:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: TSON, PRTS, FXCM, AMRI, MN Dec 05 2011 

More From Other Websites
Albany Molecular Research, Inc. breached its 50 day moving average in a Bearish Manner : AMRI-US :... May 02 2016
AMRI to Announce First Quarter 2016 Results Apr 28 2016
ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Change in Directors or Principal Officers Apr 12 2016
ALBANY MOLECULAR RESEARCH INC Financials Apr 02 2016
Albany Molecular Research, Inc. breached its 50 day moving average in a Bullish Manner : AMRI-US :... Apr 01 2016
AMRI Announces Filing of Annual Report on Form 10K Mar 30 2016
ALBANY MOLECULAR RESEARCH INC Files SEC form 10-K, Annual Report Mar 30 2016
AMRI Wins Four Life Science Leader Awards Mar 14 2016
AMRI Announces Extension to File Form 10K for 2015 Mar 11 2016
ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K/A, Entry into a Material Definitive Agreement,... Mar 01 2016
Albany Molecular Research, Inc. Earnings Analysis: 2015 By the Numbers Feb 19 2016
ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 17 2016
Edited Transcript of AMRI earnings conference call or presentation 17-Feb-16 1:30pm GMT Feb 17 2016
Albany Molecular Research posts 4Q profit Feb 17 2016
Albany Molecular Research posts 4Q profit Feb 17 2016
AMRI Announces Fourth Quarter and Full Year 2015 Results and Provides 2016 Outlook Feb 17 2016
AMRI Appoints David H. Deming and Kenneth P. Hagen to Board of Directors Feb 17 2016
Q4 2015 Albany Molecular Research Inc Earnings Release - Before Market Open Feb 17 2016
ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change... Feb 10 2016
AMRI to Announce Fourth Quarter and Full Year 2015 Results Feb 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)